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variants was negligible relative to Crp4 and lower than that induced by pro-Crp4, the inactive Crp4 precursor. Thus, Arg residues function as determinants of Crp4 bactericidal activity by facilitating or enabling target cell membrane disruption. The role of the Arg residues, however, was surprisingly independent of their position in the polypeptide chain.
INTRODUCTION
Paneth cells at the base of the crypts of Lieberkühn in the small intestine secrete apicallyoriented granules as components of innate immunity. The secretory granules are discharged in response to cholinergic stimulation or exposure to bacteria or their antigens (1-3), and they contain several antimicrobial peptides (AMPs) and proteins (4) , including lysozyme (5-7), secretory phospholipase A 2 (8) , angiogenin-4 (9), and α-defensins (10-12).
The α-defensins are cationic, amphipathic, 3-4 kDa peptides with a defining tridisulfide arrangement and β-sheet polypeptide backbone that have a broad spectrum of antimicrobial activities (13) (14) (15) . For example, mouse α-defensins, termed cryptdins (Crps), account for ~70% of the bactericidal peptide activity in secretions elicited from Paneth cells (3) , and cryptdin-4 (Crp4)
is the most potent of the known mouse α-defensin peptides (16, 17) . Also, Crps became implicated as components of mouse innate enteric immunity in vivo, when mice that lack matrix metalloproteinase-7 (MMP-7), the pro-Crp activating enzyme, were shown to have impaired host defense against oral infections (18, 19) . Remarkably, mice transgenic for human Paneth cell α-defensin HD5 express the minigene specifically in Paneth cells, and they are immune to oral infection by high doses of Salmonella enterica serovar Typhimurium (20) . Accordingly, an understanding of structure-activity relationships in α-defensins will improve the understanding of mucosal innate immune mechanisms.
To investigate the role of α-defensin primary structure in innate immunity, amino acid substitutions that alter charge were introduced into the Crp4 peptide and tested for effects on microbicidal activity and on Crp4-membrane interactions. Regardless of the site of mutagenesis, charge-reversal substitutions at Arg positions altered Crp4 bactericidal activity profoundly, and the loss of activity correlated directly with quantitative effects on peptide binding to phospholipid vesicles and with peptide-induced vesicular permeabilization.
EXPERIMENTAL PROCEDURES
Preparation of recombinant Crp4 peptide variants. -Recombinant Crp4 peptides were expressed in E. coli as N-terminal 6X-histidine tagged fusion proteins from the EcoRI and SalI sites of the pET28a expression vector (Novagen, Inc. Madison, WI) as described (21, 22) . The GCGCG AATTC ATCGA GGGAA GGATG CGCTT GTTAT GCTAT TGT as described (24) .
Mutagenesis at Arg residue positions -Mutations were introduced into Crp4 molecules by PCR as described previously (21) . In reaction #1, a mutant forward primer, e.g., Crp4-R16D-F, containing the mutant codon flanked by three natural codons was paired with reverse primer, [pMALCrp4-R], the normal reverse primer at the 3'-end of the desired sequence. In reaction #2, the mutant reverse primer, Crp4-R16D-R, the reverse-complement of the mutant forward primer, was paired with the normal forward primer, [ER1-Met-C4-F] at the 5'-end of Crp4. After ampli- Tris-Cl (pH 8.1), and clarified by centrifugation (21, 22, 24) . His-tagged Crp4 fusion peptides were purified using nickel-nitrilotriacetic acid (Ni-NTA, Qiagen) resin affinity chromatography from bacterial cells lysed in 6 M guanidine-HCl, 20 mM Tris-HCl (pH 8.1) as described (21) .
After CNBr cleavage, Crp4 peptides were purified by C18 reverse-phase high performance liquid chromatography (RP-HPLC), quantitated by bicinchoninic acid (Pierce), and molecular masses of purified peptides were determined using matrix-assisted laser desorption ionization mode mass spectrometry (Voyager-DE MALDI-TOF, PE-Biosystems, Foster City, CA) in the Mass Spectroscopy Facility, Department of Chemistry, University of California, Irvine.
Bactericidal peptide assays -Recombinant peptides were tested for microbicidal activity against E. coli ML35, S. typhimurium (PhoP-), Vibrio cholera, Staphylococcus aureus 710a, and
Listeria monocytogenes 104035 (25). Bacteria growing exponentially in trypticase soy broth at 37°C, were deposited by centrifugation at 1700 g for 10 min, washed in 10 mM PIPES (pH 7.4), and resuspended in 10 mM PIPES (pH 7.4) supplemented with 0.01 vol of trypticase soy broth (21, 22) . Bacteria (~5 x 10 6 CFU/ml) were incubated with test peptides in 50 µl for 1 h in a shaking incubator at 37°C, then 20 µl samples of incubation mixtures were diluted 1:100 with 10 mM PIPES (pH 7.4), and 50 µl of the diluted samples were plated on trypticase soy agar plates using an Autoplate 4000 (Spiral Biotech Inc., Bethesda, MD). Surviving bacteria were counted as colony forming units per ml (CFU/ml) after incubation at 37°C for 12 h to 18 h.
Peptide interactions with phospholipid/polydiacetylene (PDA) mixed vesicles. -Crp4,
and three mutant peptides with varied Arg charge-reversals were investigated for their relative membrane perturbation activities. Colorimetric phospholipid/PDA vesicles were prepared using dimyristoylphosphatidylcholine (DMPC, Sigma) as described (22) . Briefly, vesicles consisting of two parts phospholipid to three parts PDA were prepared by dissolving the phospholipids and and spectra were acquired at 28°C between 400 nm to 700 nm on a Jasco V-550 spectrophotometer (Jasco Corp., Tokyo), using a 1 cm optical path cell. Blue-to-red color transitions within the vesicle solutions, defined as the colorimetric response (% CR), were calculated as described (22, 26) . Fig 1A) were prepared using the pET-28 vector system (21) . All peptides were purified to homogeneity by RP-HPLC after chemical cleavage with CNBr as verified analytical RP-HPLC (not shown) and AU-PAGE analyses (Fig 1B) , migrating as single entities and as expected relative to native
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RESULTS
Bactericidal activities of recombinant Crp4 variants -Recombinant peptides (
Crp4 and pro-Crp4 molecules (21, 24) . The molecular masses of individual recombinant peptides were determined by MALDI-TOF MS, and they matched the respective theoretical values.
Thus, the purified recombinant peptides were homogeneous (Fig 1B) , and their biochemical features were consistent with the modifications introduced to the natural Crp4 molecule (29) .
As a first step toward investigating structure-activity relationships in Crp4, the in vitro microbicidal activities of Crp4, pro-Crp4, and selected N-terminal Crp4 variants were measured against a panel of bacterial test species (24, data not shown). The overall bactericidal activities of the N-terminal variants differed only slightly over a range of 0.6 to 10 µg/ml of peptide as observed previously (24) . In contrast to the bactericidal activities of these mature Crp4 peptide variants, pro-Crp4 lacks microbicidal activity, because MMP-7-mediated proteolysis is required for Crp4 activation (18, 19, 21) . Although the (G1D)-Crp4 peptide was consistently less active at ≤ 5 µg/ml of peptide (not shown), modifications at the Crp4 N-terminus had very modest effects on bactericidal activity (24) .
Modifications at the Crp4 C-terminus -Because the Cys1 to Cys6 disulfide bond common to α-defensins places the Crp4 N-and C-termini in proximity (13), we prepared a series of Crp4 peptide variants with charge-modified C-termini, including (R31D/R32D)-Crp4, (R31G/R32G)-Crp4, (R31V/R32V)-Crp4, and (∆R31/R32)-Crp4 (Fig 1) . Bactericidal activity assays of these variants showed that deleting the two C-terminal Arg residues or converting them to Gly or Val altered peptide activity variably, depending on the bacterial target species (com- improved with the added electropositive side chain at the N-terminus (Fig 3) . These findings showed that modifications of combined N-and C-terminal charge can modulate Crp4 bactericidal activity.
To investigate the effect of added C-terminal Arg residues on Crp4 bactericidal activity, additional modifications were introduced at the Crp4 C-terminus. C57/BL6 mice express a Crp4 variant (Crp4(B6b)) that has 4 Arg residues at its C-terminus (21), but because Crp4 and Crp4(B6b) differ at several other positions, the specific role of C-terminal charge in these peptides cannot be compared directly. Accordingly, the natural Crp4 C-terminus was extended by two Arg residues to place the Crp4-(B6b) C-terminus in the context of the Crp4 primary structure. The peptide, (R33/R34)-Crp4, had greater in vitro bactericidal peptide activity than Crp4 against E. coli and wild-type and PhoP c S. typhimurium strains (Fig 4) , suggesting that Cterminal charge could be a determinant of bactericidal activity. However, the Crp4(B6b) molecule lacks the Pro 30 residue present in Crp4 between Cys 29 and Arg 31 . Therefore, the effect of the Pro 30 residue was tested by assaying the bactericidal activity of (∆-P30/R33/R34)-Crp4, a variant of (R33/R34)-Crp4 from which Pro 30 was deleted (Fig 1) . (∆-P30/R33/R34)-Crp4 was less active than Crp4 and (R33/R34)-Crp4 against E. coli and S. typhimurium PhoP c (Fig 4) , and the results in Fig 4 also are representative of the relative bactericidal activities of these peptides against V. cholera, S. aureus, and L. monocytogenes (not shown). Thus, addition of Arg residues at the C-terminus, per se, is not sufficient to improve peptide activity in the absence of proline at residue position 30. Because the R31D/R32D C-terminal charge-reversal eliminated Crp4 bactericidal activity, the effects of charge alterations at other residue positions in the Crp4 polypeptide chain were studied to test whether the effects were specific to C-terminal modification.
Charge-reversal at Arg positions result in loss-of-function. Crp4 mutants with double
Asp for Arg substitutions were introduced at three additional Arg pairs, purified, and assayed for bactericidal peptide activity (Experimental Procedures). As was observed for (R31D/R32D)-Crp4, the R16D/R18D, R16D/R24D, and R18D/R24D variants of Crp4 all lacked bactericidal activity under the conditions of these in vitro assays (Fig 5) . Thus, loss of activity by charge reversal is not a specific effect at the C-terminus, because all peptides with double charge reversal mutations were inactive. Perhaps, Asp for Arg substitutions eliminate bactericidal activity by reducing the overall electropositivity of the Crp4 peptide. Nevertheless, it is unlikely that Arg residues at specific positions are required for Crp4 bactericidal activity, because all mutations introduced resulted in equivalent loss-of-function independent of the position of the replacements.
To determine whether a specific requirement exists for the guanidinium group of the Arg side chain in Crp4 or whether charge-neutral substitutions at Arg positions would result in peptides with equivalent bactericidal activity, we prepared (R16K/R18K)-Crp4 ( Fig 1A) and evaluated its antimicrobial activity. Because all Crp4 charge-reversal mutants were attenuated similarly, including (R16D/R18D)-Crp4, the (R16K/R18K)-Crp4 internal charge-neutral mutant was taken to be representative of such peptide alterations. As before, the Lys for Arg substituted peptide was purified to homogeneity, as in Fig 1B (data not shown) , prior to comparing its bactericidal peptide activity relative to Crp4. The bactericidal peptide activities of Crp4 and (R16K/R18K)-Crp4 were not distinguishable against E. coli, L. monocytogenes (Fig 6) or against other bacterial species (not shown). Thus, with regard to bactericidal peptide activity, Lys could replace Arg in Crp4 without effect.
Charge-reversal mutations block Crp4-membrane interactions. -To investigate the mechanisms by which charge-reversal mutagenesis of Crp4 eliminates peptide activity, we compared interactions of Crp4 and charge-reversal Crp4 mutants with membranes using colorimetric binding assays based upon lipid/PDA mixed vesicles (22) , and leakage assays from large unilamellar vesicles (24, 28) .
Crp4 loss-of-function by Arg to Asp mutagenesis correlated with the inability of mutant peptides to interact with membranes at the vesicular lipid/water interface and to perturb the hydrophobic membrane core. In the DMPC/PDA mixed vesicle system, higher %CR values correspond to interfacial lipid binding, because peptides that localize at the lipid bilayer surface induce greater perturbation in the head-group region of the lipid/polymer assembly than peptides that penetrate deeper into the hydrophobic core (32, 33) . Crp4 induced blue-red chromatic transition reaching a plateau of ~35% CR upon interaction with the phospholipid/PDA vesicles. The %CR value was dependent on peptide concentration (Fig 7) and previous work has determined that the colorimetric response indicates an interface localization of Crp4 (22, 32) . In contrast and without exception, only baseline %CR values were induced by inactive Crp4 mutants with Asp for Arg substitutions (Fig 7) . Consistent with its intermediate bactericidal activity (Fig 4) ,
(G1R/R31D/R32D)-Crp4 induced somewhat higher, intermediate %CR values between those of
Crp4 and the Crp4 variants (Fig 7) . Thus, the loss of bactericidal activity by Arg chargereversals was consistent with defective Crp4 interaction with the vesicular lipid/water interface and an inability to perturb the membrane core of the leaflet.
The membrane disruptive activities of Crp4 and inactive Crp4 variants were analyzed by comparing induced leakage of the low molecular weight fluorophore, ANTS, from large unilamellar vesicles (LUV, Experimental Procedures). Crp4 induces leakage from LUV via a "graded leakage" mechanism (24, 28) , and pro-Crp4, which lacks bactericidal activity (21, 22) , induces markedly less leakage than Crp4 and also by graded leakage that is dependent on LUV phospholipid composition ( Fig 8, 28 ). When exposed to (R31D/R32D)-Crp4, (G1D/R31D/R32D)-Crp4, and (R16D/R24D)-Crp4, ANTS-loaded LUV prepared with the anionic lipid POPG exhibited leakage that was ≤ 5% of that induced by Crp4, much less than leakage induced by pro-Crp4 (Fig 8) . Thus, regardless of the position of Arg charge-reversals in the polypeptide chain, loss-of-function was the same and corresponded directly to a loss of peptide binding to membranes and an inability to disrupt phospholipid vesicles in vitro. The bactericidal activity of mouse Paneth cell Crps is dependent on activation of proCrps from inactive 8.4 kDa proforms by MMP-7-mediated proteolysis (18, 19, 21) . For example, full-length pro-Crp4 (pro-Crp4 20-92 ) lacks bactericidal activity, and that lack of activity corresponds with a diminished ability to bind to model membranes (22) and to permeabilize LUV (28, Fig 7) . Interestingly, the two pro-Crp4 processing intermediates, pro-Crp4 44-92 and pro-Crp4 have the same bactericidal activity as the mature Crp4 peptide (H. Tanabe, S. Crampton, and A. The α-defensins from human and rabbit PMN achieve bacterial cell killing by distinctive membrane disruptive mechanisms. Neutrophil α-defensins permeabilize the outer and inner membranes of E. coli sequentially, inducing the formation of ion channels in lipid bilayers (48) , and both of these peptide-elicited effects are influenced by membrane energetics (49) . The crystal structure of human HNP-2 is a noncovalent dimer, (14) , and HNP-2 dimers form stable, 20 Å multimeric pores in LUV after insertion into model membranes (40) . In contrast, rabbit NP-1 is a monomer in solution (35) , and NP-1 permeabilizes the membrane by creating large, short-lived defects in model phospholipid bilayers (50) . Although the structure of Crp4 is not yet reported, the peptide, which has the greatest in vitro bactericidal activity among the mouse α-defensins, exhibits strong interfacial binding to model membranes (22) and induces graded fluorophore leakage from LUV (24, 28) . Thus, Crp4 resembles the NP-type α-defensin mechanism of bactericidal action, and site-directed Arg to Asp mutagenesis targets Crp4 residues that facilitate or enable that membrane disruptive mechanism. Peptide (µg/ml) Fraction of total leakage Fig 8 
